|
PPP2R5C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.68890000043598E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.23019999964669E-07 |
| Normal-vs-Stage2 |
1.890560E-01 |
| Normal-vs-Stage3 |
4.559700E-02 |
| Normal-vs-Stage4 |
9.095400E-03 |
| Stage1-vs-Stage2 |
3.714600E-01 |
| Stage1-vs-Stage3 |
1.404220E-01 |
| Stage1-vs-Stage4 |
6.804800E-01 |
| Stage2-vs-Stage3 |
9.595400E-01 |
| Stage2-vs-Stage4 |
7.325800E-01 |
| Stage3-vs-Stage4 |
5.943400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.39140000211225E-08 |
| Normal-vs-AfricanAmerican |
5.915300E-03 |
| Normal-vs-Asian |
3.517600E-02 |
| Caucasian-vs-AfricanAmerican |
2.567000E-01 |
| Caucasian-vs-Asian |
7.595600E-01 |
| AfricanAmerican-vs-Asian |
9.250200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.94110002807946E-09 |
| Normal-vs-Female |
6.960500E-02 |
| Male-vs-Female |
7.299900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.380600E-04 |
| Normal-vs-Extreme_Weight |
7.28359999979666E-07 |
| Normal-vs-Obese |
1.441570E-02 |
| Normal-vs-Extreme_Obese |
9.621300E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.833600E-01 |
| Normal_Weight-vs-Obese |
3.756200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.117000E-01 |
| Extreme_Weight-vs-Obese |
1.069960E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.588600E-01 |
| Obese-vs-Extreme_Obese |
1.763190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.465600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.442770E-03 |
| Normal-vs-Age(61-80Yrs) |
2.28380003797213E-09 |
| Normal-vs-Age(81-100Yrs) |
1.004070E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.595200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.663600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.888580E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.480300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.962800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.693000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.29980000493657E-08 |
| Normal-VS-Type2 PRCC |
8.51579999960883E-07 |
| Normal-VS-KIRP CIMP |
4.705400E-01 |
| Normal-VS-Unclassified PRCC |
8.078300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.400800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.903560E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.656800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.120800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.447800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.313420E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.36830002673128E-09 |
| Normal-vs-N1 |
9.667000E-01 |
| Normal-vs-N2 |
1.87616999999252E-05 |
| N0-vs-N1 |
1.104610E-03 |
| N0-vs-N2 |
2.753200E-01 |
| N1-vs-N2 |
2.753900E-02 |
|
|
